Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

SOD1 regulates ribosome biogenesis in KRAS mutant non-small cell lung cancer.

  • Authors : Wang X; Rutgers Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA.; Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, Piscataway, NJ, USA.

  • Source: Nature communications [Nat Commun] 2021 Apr 15; Vol. 12 (1), pp. 2259. Date of Electronic Publication: 2021 Apr 15.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

eEF2K enhances expression of PD-L1 by promoting the translation of its mRNA.

  • Authors : Wu Y; Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Yushan Road, Qingdao, China.; Xie J

  • Source: The Biochemical journal [Biochem J] 2020 Nov 27; Vol. 477 (22), pp. 4367-4381.Publisher: Published by Portland Press on behalf of the Biochemical Society Country of Publication: England NLM ID: 2984726R Publication Model: Print Cited

Record details

×
Academic Journal

ZNF300 promotes chemoresistance and aggressive behaviour in non-small-cell lung cancer.

  • Authors : Yu S; Institute of Human Respiratory Disease, Xinqiao Hospital, the Army Medical University (Third Military Medical University), Chongqing, China.; Department of Medical Biology, School of Basic Medical Science, Hubei University of Medicine, Shiyan, China.

  • Source: Cell proliferation [Cell Prolif] 2020 Nov; Vol. 53 (11), pp. e12924. Date of Electronic Publication: 2020 Oct 19.Publisher: Published for the Cell Kinetics Society, the European Study Group for Cell Proliferation, and the International Cell Cycle Society by Blackwell Scientific Publications

Record details

×
Academic Journal

Ubiquitin C-terminal hydrolase L1 promotes expression of programmed cell death-ligand 1 in non-small-cell lung cancer cells.

  • Authors : Mao R; Department of Immunology and Shandong Key Laboratory of Infection and Immunity, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, China.; Tan X

  • Source: Cancer science [Cancer Sci] 2020 Sep; Vol. 111 (9), pp. 3174-3183. Date of Electronic Publication: 2020 Jul 06.Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic

Record details

×
Academic Journal

Targeting RNA helicase DHX33 blocks Ras-driven lung tumorigenesis in vivo.

  • Authors : Wang X; Department of Biology, Southern University of Science and Technology, Shenzhen, China.; Faculty of Health Sciences, University of Macau, Macau, China.

  • Source: Cancer science [Cancer Sci] 2020 Oct; Vol. 111 (10), pp. 3564-3575. Date of Electronic Publication: 2020 Aug 24.Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic

Record details

×
Academic Journal

Knockdown of G-protein-signaling modulator 2 promotes metastasis of non-small-cell lung cancer by inducing the expression of Snail.

  • Authors : Deng M; Department of Respiratory and Infectious Disease of Geriatrics, The First Hospital of China Medical University, Shenyang, China.; Liu B

  • Source: Cancer science [Cancer Sci] 2020 Sep; Vol. 111 (9), pp. 3210-3221. Date of Electronic Publication: 2020 Aug 10.Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic

Record details

×
Academic Journal

Enhanced Anti-Brain Metastasis from Non-Small Cell Lung Cancer of Osimertinib and Doxorubicin Co-Delivery Targeted Nanocarrier.

  • Authors : Wang X; Department of Pharmaceutics and Key Laboratory of Cardiovascular & Cerebrovascular Medicine, School of Pharmacy, Nanjing Medical University, Nanjing 211166, People's Republic of China.; Mao W

  • Source: International journal of nanomedicine [Int J Nanomedicine] 2020 Aug 03; Vol. 15, pp. 5491-5501. Date of Electronic Publication: 2020 Aug 03 (Print Publication: 2020).Publisher: DOVE Medical Press Country of Publication: New Zealand NLM ID: 101263847 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma.

  • Authors : Wang S; Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, 21009, Nanjing, P.R. China.; Du M

  • Source: Nature communications [Nat Commun] 2020 Nov 27; Vol. 11 (1), pp. 6083. Date of Electronic Publication: 2020 Nov 27.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Inhibitory effect of Ubenimex combined with fluorouracil on multiple drug resistance and P-glycoprotein expression level in non-small lung cancer.

  • Authors : Wan J; Department of Thoracic Surgery, Shenzhen People's Hospital, The Second Clinical Medical College of Jinan University, The First Affiliated Hospital of South University of Science and Technology, Shenzhen, China.; Ling XA

  • Source: Journal of cellular and molecular medicine [J Cell Mol Med] 2020 Nov; Vol. 24 (21), pp. 12840-12847. Date of Electronic Publication: 2020 Sep 17.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101083777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Suppressor of Ty 16 promotes lung cancer malignancy and is negatively regulated by miR-1227-5p.

  • Authors : Yang L; Center for Translational Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Key Laboratory for Tumor Precision Medicine of Shaanxi Province, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

  • Source: Cancer science [Cancer Sci] 2020 Nov; Vol. 111 (11), pp. 4075-4087. Date of Electronic Publication: 2020 Sep 17.Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic

Record details

×
  • 1-10 of  3,661 results for ""Wang X""